GHP Investment Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

GHP Investment Advisors’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-400	Closed	-$6K	–	975
2022 Q3	$6K	Buy	+400	New	+$4.65K	﹤0.01%	773

GHP Investment Advisors's AERI Position: Q4 2022 in Review

GHP Investment Advisors sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 400 shares — an estimated $6K sold.

GHP Investment Advisors first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $6K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

GHP Investment Advisors reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
GHP Investment Advisors sold 400 Aerie Pharmaceuticals shares in Q4 2022, an estimated $6K.
GHP Investment Advisors first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
GHP Investment Advisors's Aerie Pharmaceuticals position peaked at $6K in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on GHP Investment Advisors's 13F filing for Q4 2022, filed 16 Feb 2023.